|
Volumn 52, Issue 2, 2009, Pages 559-563
|
Codrugs linking L-dopa and sulfur-containing antioxidants: new pharmacological tools against Parkinson's disease.
a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIOXIDANT;
ANTIPARKINSON AGENT;
LEVODOPA;
SULFUR;
ANALYSIS OF VARIANCE;
ANIMAL;
AREA UNDER THE CURVE;
ARTICLE;
CHEMISTRY;
CORPUS STRIATUM;
HALF LIFE TIME;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
INTRACEREBROVENTRICULAR DRUG ADMINISTRATION;
METABOLISM;
PARKINSON DISEASE;
RAT;
ULTRAVIOLET SPECTROPHOTOMETRY;
ANALYSIS OF VARIANCE;
ANIMALS;
ANTIOXIDANTS;
ANTIPARKINSON AGENTS;
AREA UNDER CURVE;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CORPUS STRIATUM;
HALF-LIFE;
HUMANS;
INJECTIONS, INTRAVENTRICULAR;
LEVODOPA;
PARKINSON DISEASE;
RATS;
SPECTROPHOTOMETRY, ULTRAVIOLET;
SULFUR;
|
EID: 60549115096
PISSN: None
EISSN: 15204804
Source Type: Journal
DOI: 10.1021/jm801266x Document Type: Article |
Times cited : (52)
|
References (0)
|